{"id":"https://openalex.org/W4412371036","doi":"https://doi.org/10.36805/jpx.v10i1.10166","title":"COST EFECTIVENESS ANALYSIS TERAPI ANTIDIABETES ORAL KOMBINASI PASIEN GEN Z RAWAT JALAN DI RS DEWI SRI","display_name":"COST EFECTIVENESS ANALYSIS TERAPI ANTIDIABETES ORAL KOMBINASI PASIEN GEN Z RAWAT JALAN DI RS DEWI SRI","publication_year":2025,"publication_date":"2025-05-31","ids":{"openalex":"https://openalex.org/W4412371036","doi":"https://doi.org/10.36805/jpx.v10i1.10166"},"language":"en","primary_location":{"id":"doi:10.36805/jpx.v10i1.10166","doi":"https://doi.org/10.36805/jpx.v10i1.10166","is_oa":true,"landing_page_url":"https://doi.org/10.36805/jpx.v10i1.10166","pdf_url":"https://journal.ubpkarawang.ac.id/Farmasi/article/download/10166/6987","source":{"id":"https://openalex.org/S4210201979","display_name":"Pharma xplore Jurnal Sains dan Ilmu Farmasi","issn_l":"2527-5801","issn":["2527-5801","2580-9601"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405255078","host_organization_name":"Universitas Buana Perjuangan Karawang","host_organization_lineage":["https://openalex.org/I4405255078"],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharma Xplore : Jurnal Sains dan Ilmu Farmasi","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://journal.ubpkarawang.ac.id/Farmasi/article/download/10166/6987","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080184171","display_name":"Dedy Frianto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096913","display_name":"University of Singaperbangsa Karawang","ror":"https://ror.org/00vc1fz20","country_code":"ID","type":"education","lineage":["https://openalex.org/I4210096913"]}],"countries":["ID"],"is_corresponding":false,"raw_author_name":"Dedy Frianto","raw_affiliation_strings":["Program Studi Farmasi , Fakultas Farmasi , Universitas Buana Perjuangan Karawang , Karawang , Jawa Barat , Indonesia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Program Studi Farmasi , Fakultas Farmasi , Universitas Buana Perjuangan Karawang , Karawang , Jawa Barat , Indonesia","institution_ids":["https://openalex.org/I4210096913"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5118966434","display_name":"Ayu Wandira","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096913","display_name":"University of Singaperbangsa Karawang","ror":"https://ror.org/00vc1fz20","country_code":"ID","type":"education","lineage":["https://openalex.org/I4210096913"]}],"countries":["ID"],"is_corresponding":false,"raw_author_name":"Ayu Wandira","raw_affiliation_strings":["Program Studi Farmasi , Fakultas Farmasi , Universitas Buana Perjuangan Karawang , Karawang , Jawa Barat , Indonesia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Program Studi Farmasi , Fakultas Farmasi , Universitas Buana Perjuangan Karawang , Karawang , Jawa Barat , Indonesia","institution_ids":["https://openalex.org/I4210096913"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027283502","display_name":"Lina Aliyani Mardiana","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096913","display_name":"University of Singaperbangsa Karawang","ror":"https://ror.org/00vc1fz20","country_code":"ID","type":"education","lineage":["https://openalex.org/I4210096913"]}],"countries":["ID"],"is_corresponding":false,"raw_author_name":"Lina Aliyani Mardiana","raw_affiliation_strings":["Program Studi Farmasi , Fakultas Farmasi , Universitas Buana Perjuangan Karawang , Karawang , Jawa Barat , Indonesia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Program Studi Farmasi , Fakultas Farmasi , Universitas Buana Perjuangan Karawang , Karawang , Jawa Barat , Indonesia","institution_ids":["https://openalex.org/I4210096913"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210096913"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.16243686,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"10","issue":"1","first_page":"210","last_page":"219"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.8687000274658203,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.8687000274658203,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.11710000038146973,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9079999923706055},{"id":"https://openalex.org/keywords/generation-z","display_name":"Generation Z","score":0.8130000233650208},{"id":"https://openalex.org/keywords/oral-antidiabetic-drugs","display_name":"oral antidiabetic drugs","score":0.8889999985694885},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.9539999961853027},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9449999928474426},{"id":"https://openalex.org/keywords/glibenclamide","display_name":"glibenclamide","score":0.9010000228881836},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.9649999737739563},{"id":"https://openalex.org/keywords/acarbose","display_name":"acarbose","score":0.9900000095367432},{"id":"https://openalex.org/keywords/glimepiride","display_name":"glimepiride","score":0.9660000205039978},{"id":"https://openalex.org/keywords/direct-medical-costs","display_name":"direct medical costs","score":0.6890000104904175},{"id":"https://openalex.org/keywords/random-blood-glucose","display_name":"random blood glucose","score":0.7329999804496765},{"id":"https://openalex.org/keywords/outpatients","display_name":"outpatients","score":0.45899999141693115}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.39509111642837524},{"id":"https://openalex.org/C127313418","wikidata":"https://www.wikidata.org/wiki/Q1069","display_name":"Geology","level":0,"score":0.3475228548049927}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.36805/jpx.v10i1.10166","doi":"https://doi.org/10.36805/jpx.v10i1.10166","is_oa":true,"landing_page_url":"https://doi.org/10.36805/jpx.v10i1.10166","pdf_url":"https://journal.ubpkarawang.ac.id/Farmasi/article/download/10166/6987","source":{"id":"https://openalex.org/S4210201979","display_name":"Pharma xplore Jurnal Sains dan Ilmu Farmasi","issn_l":"2527-5801","issn":["2527-5801","2580-9601"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405255078","host_organization_name":"Universitas Buana Perjuangan Karawang","host_organization_lineage":["https://openalex.org/I4405255078"],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharma Xplore : Jurnal Sains dan Ilmu Farmasi","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.36805/jpx.v10i1.10166","doi":"https://doi.org/10.36805/jpx.v10i1.10166","is_oa":true,"landing_page_url":"https://doi.org/10.36805/jpx.v10i1.10166","pdf_url":"https://journal.ubpkarawang.ac.id/Farmasi/article/download/10166/6987","source":{"id":"https://openalex.org/S4210201979","display_name":"Pharma xplore Jurnal Sains dan Ilmu Farmasi","issn_l":"2527-5801","issn":["2527-5801","2580-9601"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405255078","host_organization_name":"Universitas Buana Perjuangan Karawang","host_organization_lineage":["https://openalex.org/I4405255078"],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharma Xplore : Jurnal Sains dan Ilmu Farmasi","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4412371036.pdf","grobid_xml":"https://content.openalex.org/works/W4412371036.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2899084033","https://openalex.org/W2748952813","https://openalex.org/W3031052312","https://openalex.org/W4389568370","https://openalex.org/W3032375762","https://openalex.org/W1995515455","https://openalex.org/W2080531066","https://openalex.org/W3108674512","https://openalex.org/W1506200166","https://openalex.org/W1489783725"],"abstract_inverted_index":{"The":[0,115,141,160],"prevalence":[1],"of":[2,42,64,98,157,162,179,208,236,244],"type":[3],"2":[4,227],"diabetes":[5],"mellitus":[6],"among":[7],"younger":[8],"age":[9],"groups,":[10],"including":[11],"Generation":[12,73,99,184],"Z":[13,74,100,185],"(born":[14],"1997\u20132012),":[15],"has":[16],"increased":[17],"significantly.":[18],"Combination":[19],"therapy":[20,109,259],"using":[21],"oral":[22,66,106],"antidiabetic":[23,67,107],"drugs":[24],"is":[25,83],"a":[26,84,88,177,237,252],"preferred":[27],"approach":[28],"to":[29,47,60,153,172,193,225],"optimally":[30],"control":[31],"blood":[32,138],"glucose":[33,139],"levels.":[34,140],"However,":[35],"the":[36,52,62,95,121,134,155,158,194,213,234],"clinical":[37],"effectiveness":[38,156],"and":[39,146,257],"cost":[40,116,243],"burden":[41],"various":[43],"drug":[44],"combinations":[45],"need":[46],"be":[48,173],"analyzed,":[49],"especially":[50],"considering":[51],"country's":[53],"limited":[54],"healthcare":[55],"budget.":[56],"This":[57,81],"study":[58,86],"aims":[59],"assess":[61],"cost-effectiveness":[63],"different":[65],"combination":[68,108,161],"therapies":[69],"used":[70,152],"by":[71,124],"outpatient":[72,183],"patients":[75,101,186],"at":[76,110,187],"Dewi":[77,111,188],"Sri":[78,112,189],"Karawang":[79,113,190],"Hospital.":[80,114],"research":[82],"descriptive-analytic":[85],"with":[87,176],"cross-sectional":[89],"approach.":[90],"Data":[91],"were":[92,151],"obtained":[93],"from":[94,120,217],"medical":[96,127],"records":[97],"(aged":[102],"12\u201327":[103],"years)":[104],"undergoing":[105],"analysis":[117],"was":[118,130,170],"conducted":[119],"hospital's":[122],"perspective":[123],"calculating":[125],"direct":[126],"costs.":[128],"Effectiveness":[129],"measured":[131],"based":[132],"on":[133,212],"reduction":[135],"in":[136,233],"random":[137],"Average":[142],"Cost-Effectiveness":[143,148],"Ratio":[144,149],"(ACER)":[145],"Incremental":[147],"(ICER)":[150],"compare":[154],"therapies.":[159],"Glibenclamide":[163],"5":[164],"mg":[165,169,197,201,220,224,228],"+":[166,198,221,229],"Metformin":[167,199,222,230],"500":[168,200,223,231],"found":[171],"more":[174],"cost-effective,":[175],"result":[178],"IDR":[180,209,245],"4,614/mg/dL":[181],"for":[182,254],"Hospital,":[191],"compared":[192],"Acarbose":[195,218],"50":[196,219],"combination,":[202],"which":[203],"had":[204],"an":[205,241],"ACER":[206],"value":[207],"8,744/mg/dL.":[210],"Based":[211],"ICER":[214],"calculation,":[215],"switching":[216],"Glimepiride":[226],"mg,":[232],"event":[235],"stock-out,":[238],"would":[239],"require":[240],"additional":[242],"61,288/mg/dL.":[246],"These":[247],"findings":[248],"may":[249],"serve":[250],"as":[251],"consideration":[253],"making":[255],"efficient":[256],"affordable":[258],"decisions.":[260]},"counts_by_year":[],"updated_date":"2026-10-07T09:51:55.459714","created_date":"2025-10-10T00:00:00"}